| Serial Number | 98614898 |
| Word Mark | EVOLVERAI |
| Filing Date | Monday, June 24, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 17, 2025 |
| Goods and Services | Downloadable computer software using artificial intelligence for automated machine learning in the field of drug design and development; Downloadable computer software using artificial intelligence for collecting, analyzing, interpreting, and reporting data and information for drug design and development; Downloadable computer software using artificial intelligence for automated machine learning for drug design and development in the fields of neuroscience and immuno-oncology; Downloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Downloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of neuroscience and immune-oncology; Downloadable computer software for molecular research, research and develop and development of pharmaceutical products and chemical compounds, and analysis of biological or chemical activity in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Downloadable artificial intelligence software for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, development, and response prediction in the fields of neuroscience and immune-oncology; Downloadable software using artificial intelligence and incorporating computational methods and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development. |
| Goods and Services | Providing online nondownloadable computer software using artificial intelligence for automated machine learning in the field of drug design and development; Providing online nondownloadable computer software using artificial intelligence for collecting, analyzing, interpreting, and reporting data and information for drug design and development; Providing online nondownloadable computer software using artificial intelligence for automated machine learning for drug design and development in the fields of neuroscience and immune-oncology; Providing online nondownloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Providing online nondownloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of neuroscience and immune-oncology; Providing online nondownloadable software for molecular research, research and development of pharmaceutical products and chemical compounds, and analysis of biological or chemical activity in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Providing online nondownloadable artificial intelligence software for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, development, and response prediction in the fields of neuroscience and immuno-oncology; Providing online nondownloadable software using artificial intelligence and incorporating computational methods and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for collecting, analyzing, interpreting, and reporting data and information for drug design and development; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for automated machine learning for drug design and development in the fields of neuroscience and immune-oncology; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of neuroscience and immune-oncology; Platform as a service (PaaS) featuring computer software platforms for molecular research, research and development of pharmaceutical products and chemical compounds, and analysis of biological or chemical activity in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, development, and response prediction in the fields of neuroscience and immuno-oncology; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence and incorporating computational methods and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; Pharmaceutical and biopharmaceutical research and development; Pharmaceutical and biopharmaceutical research and development in the fields of neuroscience and immuno-oncology; Scientific and medical research in the fields of pharmaceuticals, biologic testing and interpretation, neuroscience, and immuno-oncology; Research and development of pharmaceuticals, biological preparations, and therapeutic products and medicines. |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 24, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 24, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BIOXCEL LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New Haven, CT 06511 |
| Party Name | BIOXCEL LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New Haven, CT 06511 |
| Event Date | Event Description |
| Monday, June 24, 2024 | NEW APPLICATION ENTERED |
| Monday, January 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 18, 2025 | NON-FINAL ACTION E-MAILED |
| Saturday, January 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 14, 2025 | ASSIGNED TO EXAMINER |
| Saturday, January 18, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, April 18, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 18, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 18, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 11, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 17, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 17, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |